Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

171
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
171
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

321
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
321
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.6K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.6K
Nonlinear Pharmacokinetics: Causes of Nonlinearity01:22

Nonlinear Pharmacokinetics: Causes of Nonlinearity

485
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
485
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

781
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
781
Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs01:21

Fundamental Mathematical Principles in Pharmacokinetics: Calculus and Graphs

2.5K
The fundamental mathematical principles, such as calculus and graphs, play crucial roles in analyzing drug movement and determining pharmacokinetic parameters. Differential calculus examines rates of change and helps to determine the dissolution rate of drugs in biofluids, as well as how drug concentrations change over time. For instance, it can help calculate the rate of elimination of a drug from the body based on its concentration-time profile.
On the other hand, integral calculus focuses on...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging findings of hepatic storage diseases.

Radiologia·2026
Same author

Search for Signatures of Dark Matter Annihilation in the Galactic Center with HAWC.

Physical review letters·2026
Same author

QuiCAT: a scalable and flexible framework for mapping synthetic sequences.

Bioinformatics (Oxford, England)·2025
Same author

Neuroimaging and immunofluorescence of the Pseudopus apodus brain: unraveling its structural complexity.

Brain structure & function·2025
Same author

Changes in biogeographic patterns of coastal fishes: Indicators of tropicalization in the Canary Islands over the last 40 years.

Marine environmental research·2025
Same author

Novel nanostructured lipid carriers loading Apigenin for anterior segment ocular pathologies.

International journal of pharmaceutics·2024

Related Experiment Video

Updated: Nov 15, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.5K

Combination anti-coronavirus therapies based on nonlinear mathematical models.

J A González1, Z Akhtar2, D Andrews3

  • 1Department of Physics, Florida International University, Miami, Florida 33199, USA.

Chaos (Woodbury, N.Y.)
|March 3, 2021
PubMed
Summary

New combination therapies for COVID-19 were designed using mathematical models and experimental data. These novel approaches leverage nonlinear mathematical models and extensive data for improved treatment strategies.

More Related Videos

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.5K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.1K

Related Experiment Videos

Last Updated: Nov 15, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.5K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.5K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.1K

Area of Science:

  • Mathematical Biology
  • Infectious Disease Research
  • Pharmacology

Background:

  • COVID-19 remains a significant global health challenge.
  • Existing therapies have limitations in efficacy and resistance.
  • The need for innovative treatment strategies is critical.

Purpose of the Study:

  • To design novel combination therapies for COVID-19.
  • To utilize nonlinear mathematical models for therapeutic development.
  • To integrate experimental data for robust treatment design.

Main Methods:

  • Development of nonlinear mathematical models.
  • Analysis of laboratory and clinical study data.
  • In silico design and validation of combination therapies.

Main Results:

  • Identification of promising synergistic drug combinations.
  • Mathematical models accurately predicted therapeutic outcomes.
  • Experimental validation confirmed the efficacy of designed therapies.

Conclusions:

  • Nonlinear mathematical modeling is a powerful tool for designing COVID-19 combination therapies.
  • The designed therapies show potential for improved clinical outcomes.
  • Further research and clinical trials are warranted to evaluate these novel treatments.